Elsevier

Brain Research

Volume 495, Issue 2, 28 August 1989, Pages 401-406
Brain Research

Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systematic amphetamine

https://doi.org/10.1016/0006-8993(89)90236-9Get rights and content

Abstract

Pre-exposure of rats to systemic injections ofd-amphetamine sulfate in the presence of bilateral injections of Sch-23390 (0.5 or 1.0 μg/side) into the ventral tegmental area (VTA) attenuated the acute locomotor effects of amphetamine and blocked the development of sensitization to amphetamine in a test when only amphetamine was administered, in a dose-dependent manner. Similar, but less potent, effects were observed following injections into substantia nigra pars reticulata. These findings suggest that dopamine released from somatodendritic regions brings about changes in local circuitry in the VTA that underlie the development of sensitization to amphetamine, and that Sch-23390 acts at D1 receptors in these regions to block these changes.

References (41)

  • JacksonE.A. et al.

    Role of nigral dopamine in amphetamine-induced locomotor activity

    Brain Research

    (1983)
  • JacksonE.A. et al.

    Effects of intranigra injections of dopamine agonists and antagonists, glycine, muscimol and N-methyl-d.l-aspartate on locomotor activity

    Brain Res. Bull.

    (1984)
  • KamataK. et al.

    Nigral reticula neurons: potentiation of responsiveness to amphetamine with long-term treatment

    Brain Research

    (1985)
  • KoltaM.G. et al.

    Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine

    Neuropharmacology

    (1985)
  • KuczenskiR. et al.

    Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?

    Pharmacol. Biochem. Behav.

    (1981)
  • KurumiyaS. et al.

    Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation

    Brain Research

    (1988)
  • McQuadeR.D. et al.

    Serotonergic component of SCH 23390: in vitro and in vivo binding analyses

    Life Sci.

    (1988)
  • MereuG. et al.

    SCH 23390, a selective dopamine D1 antagonist. Activates dopamine neurons but fails to prevent their inhibition by apomorphine

    Eur. J. Pharmacol.

    (1985)
  • OldsM.E.

    The responses of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence

    Brain Research

    (1988)
  • PorcedduM.L. et al.

    3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine

    Life Sci.

    (1986)
  • Cited by (0)

    *

    Present address: Chaire de Neuropharmacologie, I.N.S.E.R.M. U114, College de France, 11 Place Marcelin Berthelot, 75231 Paris Cedex 5, France.

    View full text